Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Dermatology. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.
A new study has found that obese patients with metastatic melanoma live significantly longer than those with a normal body mass index — especially male patients treated with targeted or immune therapy.
- Northwestern Notables: A Lasting Legacy-Dermatology03.01.2018
Immune cells migrating from the bloodstream to the brain may contribute to seizures in pediatric epilepsy, according to new findings published in the Journal of Experimental Medicine.
Daycares and early childhood education programs frequently use spray sunscreen on children, but still have room for improvement when it comes to sun safety, according to a new Northwestern Medicine study.
Antibodies that reverse immune system suppression may be able to be used to treat a rare type of melanoma, according to a Northwestern Medicine study published in the journal Nature.
- Chief of Oncodermatology Division, Jennifer Choi, MD, featured in recent Dermatology News article01.23.2018
<a href="http://www.feinberg.northwestern.edu/faculty-profiles/az/profile.html?xid=15591">Roopal Kundu, ’01 MD, ’02 GME</a>, guides students through the admissions process and beyond.
- Chair of Dermatology, Amy Paller, MD, selected as the recipient of the 2018 Wilma Bergfeld MD Visionary and Leadership Award12.11.2017
The Department of Dermatology is proud to announce that our very own Chair of Dermatology, Amy Paller, MD, has been selected by her colleagues of the Women's Dermatologic Society to be the recipient of the 2018 Wilma Bergfeld, MD Visionary & Leadership Award.
She will receive the award in San Diego on Sunday, February 18, 2018.
Scientists in the Department of Dermatology are working hard to better understand the fundamentals of skin biology and to bring those discoveries to the forefront of skin treatment.
Two Northwestern Medicine scientists have received NIH Director’s Awards, which fund innovative research with high-impact potential.
- Eversight announces grant award for Northwestern University researcher, Han Peng, PhD08.18.2017
ANN ARBOR, Mich. — Eversight, a global nonprofit network of eye banks, has awarded a $15,000 Eye and Vision Research Grant to Northwestern University’s Han Peng, Ph.D.
Dr. Peng was among nine recipients who received grants from Eversight for projects that aligned with the organization’s mission to restore sight and prevent blindness. The awards were determined by an independent review panel composed of distinguished scientists, ophthalmologists and health services researchers.
Dr. Peng, a research assistant professor in the department of dermatology at Feinberg School of Medicine, is investigating a possible approach for improving the treatment of limbal stem cell deficiency (LSCD), a problem that is often not recognized and treated in its early stages and may lead to corneal ulceration, scarring, chronic pain and vision loss.
LSCD occurs because of the loss of limbal epithelial stem cells, but Dr. Peng’s research hypothesizes that an enzyme his team has identified, factor inhibiting hypoxia-inducible factor 1 (FIH-1), may preserve more stem cells. The establishment of stem-cell enriched cultures has the potential to significantly improve the outcome of corneal transplantation for patients with LSCD.
The Eye and Vision Research Grant program has awarded more than $3.5 million since 1980 to stimulate new and pioneering research. Several of these grant projects have led to larger studies and financial support from the National Institutes of Health.
“There’s a real void when it comes to funding the initial investigative work that can launch new and groundbreaking discoveries,” said Dr. Gregory Grossman, Eversight Director of Research. “But Eversight is committed to supporting research that may potentially lead to innovative therapies and treatments.”
The Eversight Center for Eye and Vision Research is one of the only eye bank-led programs focused on providing scientists with innovative resources they need to find new cures and treatments for blinding eye conditions. For more information, visit eversightvision.org/research.
– More –
About Eversight: Eversight is a charitable, 501(c)(3) not-for-profit organization whose mission is to restore sight and prevent blindness through the healing power of donation, transplantation and research. Our network of community eye banks—in Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea—is responsible for recovering, evaluating and providing human eye tissue for transplantation; supporting research into the causes and cures of blinding eye conditions; promoting donation awareness through public and professional education; and providing humanitarian aid to people around the world in need of corneal transplantation. For more information, visit eversightvision.org.
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
Consumer complaints for cosmetic products have more than doubled, but consumers may remain at risk because the industry receives little regulatory scrutiny, according to new research.
A new study has demonstrated how a specific class of immune cells represent a previously unknown link between high cholesterol and the development of symptoms characteristic of psoriasis.
Northwestern Medicine scientists showed how a microRNA family regulates aspects of autophagy and macropinocytosis in the stem cell–enriched limbal epithelium of the eye.
A Northwestern research team has developed a first-of-its-kind flexible microfluidic device that adheres to the skin and measures the wearer’s sweat.
Nearly 40 percent of patients with atopic dermatitis saw their disease completely or almost completely cleared with a new drug called dupilumab, according to a Northwestern Medicine clinical trial.
Kathleen Green, PhD, Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been elected to the German National Academy of Sciences for her scientific achievements.
Forty percent of top-selling sunscreens don’t meet national standards for protection, and consumers are spending up to 3,000 percent more for products that provide equivalent benefit, according to new research.
Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
Patients with psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab in three recent clinical trials led by a Northwestern Medicine investigator
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
- Children With Common Allergies Have Twice Heart Disease Risk: Jonathan Silverberg, MD, published in Dec 8 edition of the Journal of Allergy & Clinical Immunology12.08.2015New study by Jonathan Silverberg, MD published in the Dec 8 edition of the Journal of Allergy & Clinical Immunology shows that allergies are tied to higher blood pressure and cholesterol levels.
Blocking the sodium channel protein Nax decreased scarring and atopic dermatitis, an inflammatory skin disorder, by improving the skin’s barrier function in a new Northwestern Medicine study.
In a recent study, Northwestern Medicine scientists described a new process that explains how the adhesion between epithelial cells occurs.
Kathleen Green, PhD, Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology, has received a Humboldt Research Award, which recognizes her achievements in epithelial cell biology and provides her the opportunity to visit Germany for research collaborations.
Northwestern Medicine investigators published the results of a clinical trial showing that a new psoriasis drug called guselkumab has greater efficacy than the current standard of care.
New Northwestern Medicine research shows spherical nucleic acids can silence a gene that interferes with wound healing, opening the door to new treatments for diabetic skin wounds, as well as many other conditions.
Northwestern Medicine scientists are testing a new flexible electronic material for safety on skin that could be used to collect noninvasive data for diagnosis of neurological disorders and brain-computer interfaces.
Northwestern Medicine scientists have discovered that scar-forming cells in scleroderma come from fat tissue within layers of the skin, a new cellular origin that could be a key to developing treatments for the incurable disease.